Danish pharmaceutical company Novo Nordisk is set to launch its anti-diabetes and weight-loss drug Wegovy in India, aiming to outperform Eli Lilly's Mounjaro. Regulatory approval for Wegovy's cardiovascular benefits has been granted, pending final approval, allowing cardiologists to prescribe it.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/pK6I3uf
via IFTTT
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(264)
-
▼
April
(64)
- SS Innovations International to list on US exchang...
- Reckitt Benckiser's rare reflection: India a big g...
- To speed up delivery, govt exempts orphan drugs fr...
- Relief for pharma cos as Delhi HC says cough syrup...
- Delhi HC orders cough syrup makers to warn against...
- Drugs panel considering proposal to rein in sale o...
- Aurobindo Pharma arm gets USFDA nod for generic bl...
- Pharma & healthcare deals see shifting focus on sc...
- Novo Nordisk to phase out key drug, insulin cos sp...
- Dr Reddy's, Lupin recall products in US due to lab...
- India faces a silent cervical cancer crisis: Every...
- Novo Nordisk to discontinue Human Mixtard, India's...
- Russia-Ukraine war: Indian pharma firm caught in c...
- Shivinder Mohan Singh moves NCLT, files plea for p...
- Pharmacists seek clarity on banned cough syrup stock
- Centre pushes for 'one nation, one swap transplant...
- Yoga vs Strengthening exercises: Which is better f...
- US tariff chaos, global headwinds hit pharma GCC h...
- Shedding weight may no longer be a prickly issue a...
- Health ministry in talks to shield India’s pharma ...
- Divi's Lab inks supply pact with global pharmaceut...
- Govt bans select cough syrups for kids below 4 years
- Alembic Pharma gets USFDA nod for generic drug
- Assam govt plans to transform GMCH into one of Ind...
- Trump’s executive order on drug pricing could be a...
- In major development in pharma, halt order enforce...
- Mercury soars, and so do sales of rehydration drin...
- AstraZeneca Pharma India surrenders marketing auth...
- Biocon Biologics secures market entry for Yesafili...
- Sweet Surrender: Sanofi puts star insulin brand La...
- Pharma companies may feel heat of US tariffs on China
- 'Factually incorrect': Dr Reddy's denies 25% workf...
- Dr Reddy’s slashing jobs to cut costs by 25%; asks...
- India's healthcare expenditure expected to surge f...
- Glenmark, Sun Pharma, Zydus recall products in US
- Healthcare investors go for full-body check-up: Fo...
- Any tariffs on pharma sector would be counterprodu...
- Weight is over! Pharma companies race to make weig...
- USFDA issues Form 483 with 11 observations to Rale...
- Morepen to hire 1,000 medical representatives to s...
- Cipla gets USFDA nod for generic cancer drug
- Tariff risks cloud near-term pharma deals outlook:...
- US court lifts restrictions on Sun Pharma launchin...
- Natco to sell rare spinal disease drug Risdiplam f...
- ZIM Labs inks pact with Globalpharma Co to commerc...
- Trump signals major tariff on pharma imports, Indi...
- As Empagliflozin goes off patent, 71 copies of the...
- India's anti-obesity drug market has grown more th...
- India’s anti-obesity drug market quadruples in fiv...
- PE firms bet on small-town hospitals for a growth ...
- Sun Pharma launches medication for Erosive Esophag...
- Novo Nordisk readies to bring weight-loss drug Weg...
- Govt plans capacity building activities for frontl...
- Indians are quitting the safety net of health insu...
- Kerala launches digital payment system, online ser...
- Now Pharma Inc looks for cure as Trump delivers do...
- People Tree Hospital Secures 25 Million USD (₹220 ...
- T-Rx: Indian pharma majors breathe easy as US spar...
- 'Pharma's exemption from reciprocal tariffs unders...
- Big relief for India! Trump spares pharma from har...
- Fortis healthcare buys disputed Fortis trademark f...
- Lupin acquires UK-based firm for 12.3 million pounds
- Market volatility derails Novartis' plan to sell s...
- 360 ONE, Claypond Capital get CCI nod to acquire s...
-
▼
April
(64)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment